Novo Nordisk has announced the promotion of Andy Ajello to vice president, national diabetes sales, managed care and government accounts. Ajello joins the executive team and will report to Jerzy Gruhn, president of Novo Nordisk’s North American affiliate. Ajello was most recently associate vice president of diabetes sales for the eastern area.
Merck announced that Carlos Represas, chairman of Nestlé Mexico, has been elected to the company’s board of directors, effective Feb. 24. Represas will become one of 13 outside directors on the 14-member board. Prior to Nestlé Mexico, Represas was EVP and head of the Americas business for Nestlé S.A.
